Removal of the calpain 3 protease reverses the myopathology in a mouse model for titinopathies - Laboratoire Analyse et Modélisation pour la Biologie et l'Environnement Accéder directement au contenu
Article Dans Une Revue Human Molecular Genetics Année : 2010

Removal of the calpain 3 protease reverses the myopathology in a mouse model for titinopathies

Karine Charton
Nathalie Danièle
Carinne Roudaut
Evelyne Gicquel
François Monjaret
  • Fonction : Auteur
  • PersonId : 1308116
  • IdRef : 177577673
Isabelle Richard

Résumé

The dominant tibial muscular dystrophy (TMD) and recessive limb-girdle muscular dystrophy 2J are allelicdisorders caused by mutations in the C-terminus of titin, a giant sarcomeric protein. Both clinical presentationswere initially identified in a large Finnish family and linked to a founder mutation (FINmaj). To furtherunderstand the physiopathology of these two diseases, we generated a mouse model carrying the FINmajmutation. In heterozygous mice, dystrophic myopathology appears late at 9 months of age in few distalmuscles. In homozygous (HO) mice, the first signs appear in the Soleus at 1 month of age and extend tomost muscles at 6 months of age. Interestingly, the heart is also severely affected in HO mice. The mutationleads to the loss of the very C-terminal end of titin and to a secondary deficiency of calpain 3, a partner oftitin. By crossing the FINmaj model with a calpain 3-deficient model, the TMD phenotype was corrected,demonstrating a participation of calpain 3 in the pathogenesis of this disease.

Mots clés

Dates et versions

hal-02321460 , version 1 (21-10-2019)

Identifiants

Citer

Karine Charton, Nathalie Danièle, Anna Vihola, Carinne Roudaut, Evelyne Gicquel, et al.. Removal of the calpain 3 protease reverses the myopathology in a mouse model for titinopathies. Human Molecular Genetics, 2010, 19 (23), pp.4608-4624. ⟨10.1093/hmg/ddq388⟩. ⟨hal-02321460⟩
68 Consultations
0 Téléchargements

Altmetric

Partager

Gmail Facebook X LinkedIn More